January 2012

Twitter Has Changed the News – What it Means for Pharma

Twitter Has Changed the News – What it Means for Pharma

Eye on FDA

FDA OKs Vertex Drug For Cystic Fibrosis; $294K/Yr

FDA OKs Vertex Drug For Cystic Fibrosis; $294K/Yr

Pharmalot

2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012

2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012

Seeking Alpha

GlaxoSmithKline Poised To Break 52-Week High

GlaxoSmithKline Poised To Break 52-Week High

Seeking Alpha

AcelRx rallies on drug study update

AcelRx rallies on drug study update

Marketwatch

Actelion Counts on ‘Make or Break’ Lung Drug

Actelion Counts on ‘Make or Break’ Lung Drug

Bloomberg

Which Big Biotech Is the Best Bet?

Which Big Biotech Is the Best Bet?

Motley Fool

3 Biotech Buyout Candidates for 2012

3 Biotech Buyout Candidates for 2012

Motley Fool

FDA Pharma Meetings for February

FDA Pharma Meetings for February

Motley Fool

Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug

Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug

Yahoo/AP